BRPI0515559A - vacina e método para a preparação da mesma - Google Patents
vacina e método para a preparação da mesmaInfo
- Publication number
- BRPI0515559A BRPI0515559A BRPI0515559-2A BRPI0515559A BRPI0515559A BR PI0515559 A BRPI0515559 A BR PI0515559A BR PI0515559 A BRPI0515559 A BR PI0515559A BR PI0515559 A BRPI0515559 A BR PI0515559A
- Authority
- BR
- Brazil
- Prior art keywords
- candida
- ccm
- vaccine
- preparing
- candidamycoses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"VACINA E MéTODO PARA A PREPARAçãO DA MESMA". A presente invenção refere-se a uma nova vacina, seu uso para a imunoprofilaxia e/ou tratamento de candidomicoses em medicina veterinária e humana, bem como a métodos para sua preparação, em que a referida vacina consiste de uma combinação de cepas de Cândida: a1) Candida albicans CCM 8355; a2) Candida glabrata CCM 8356; a3) Candida krusei CCM 8357; e a4) uma cepa de imunomodulação Propionibacterium acnes, e opcionalmente excipientes farmaceuticamnte aceitáveis, tais como veículos, em que a razão ds componentes a1-a4 no produto final a1:a2:a3:a4 é 10-20: 10-20: 40-70.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004046391A DE102004046391A1 (de) | 2004-09-24 | 2004-09-24 | Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie |
| PCT/EP2005/010347 WO2006032533A1 (de) | 2004-09-24 | 2005-09-23 | Neuer impfstoff für veterinäre und humanmedizinische prophylaxe und therapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0515559A true BRPI0515559A (pt) | 2008-07-29 |
Family
ID=35453456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0515559-2A BRPI0515559A (pt) | 2004-09-24 | 2005-09-23 | vacina e método para a preparação da mesma |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7648698B2 (pt) |
| EP (1) | EP1791601B1 (pt) |
| JP (1) | JP2008514568A (pt) |
| CN (1) | CN101084042A (pt) |
| AT (1) | ATE489997T1 (pt) |
| AU (1) | AU2005287473A1 (pt) |
| BR (1) | BRPI0515559A (pt) |
| CA (1) | CA2579787A1 (pt) |
| DE (2) | DE102004046391A1 (pt) |
| MX (1) | MX2007003164A (pt) |
| PL (1) | PL1791601T3 (pt) |
| RU (1) | RU2007115160A (pt) |
| WO (1) | WO2006032533A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2184997A4 (en) * | 2007-07-31 | 2010-11-03 | Univ New York | DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES |
| FR2993179B1 (fr) * | 2012-07-13 | 2016-01-08 | Lesaffre & Cie | Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales |
| UA125386C2 (uk) * | 2018-12-27 | 2022-03-02 | Ігор Семенович Марков | Інактивована рідка вакцина проти кандидозу, спосіб її отримання та спосіб лікування і профілактики нею |
| US11273190B2 (en) | 2019-05-06 | 2022-03-15 | Kenda Rigdon | Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH639280A5 (de) * | 1977-12-23 | 1983-11-15 | Solco Basel Ag | Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom. |
| DE3817762A1 (de) * | 1988-05-26 | 1989-11-30 | Sanum Kehlbeck Gmbh & Co Kg | Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben |
| CS277558B6 (cs) | 1991-11-28 | 1993-02-17 | Lekarska Fakulta Up | Vakcina k léčbě vleklých kvasinkových zánětů pochvy |
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB9801870D0 (en) * | 1998-01-28 | 1998-03-25 | Raby Limited | Vaccine composition |
| KR100407128B1 (ko) | 2000-10-20 | 2003-11-28 | 주식회사 바이오리 | 송화가루 또는 송화가루 추출물을 함유하는 피부외용제 |
| US7914799B2 (en) * | 2001-08-27 | 2011-03-29 | Immunitor USA, Inc. | Anti-fungal composition |
-
2004
- 2004-09-24 DE DE102004046391A patent/DE102004046391A1/de not_active Withdrawn
-
2005
- 2005-09-23 JP JP2007532852A patent/JP2008514568A/ja active Pending
- 2005-09-23 CN CNA2005800321393A patent/CN101084042A/zh active Pending
- 2005-09-23 US US11/574,808 patent/US7648698B2/en not_active Expired - Fee Related
- 2005-09-23 RU RU2007115160/15A patent/RU2007115160A/ru not_active Application Discontinuation
- 2005-09-23 AU AU2005287473A patent/AU2005287473A1/en not_active Abandoned
- 2005-09-23 MX MX2007003164A patent/MX2007003164A/es not_active Application Discontinuation
- 2005-09-23 BR BRPI0515559-2A patent/BRPI0515559A/pt not_active IP Right Cessation
- 2005-09-23 WO PCT/EP2005/010347 patent/WO2006032533A1/de active Application Filing
- 2005-09-23 EP EP05786111A patent/EP1791601B1/de not_active Not-in-force
- 2005-09-23 AT AT05786111T patent/ATE489997T1/de active
- 2005-09-23 PL PL05786111T patent/PL1791601T3/pl unknown
- 2005-09-23 CA CA002579787A patent/CA2579787A1/en not_active Abandoned
- 2005-09-23 DE DE502005010631T patent/DE502005010631D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20080254068A1 (en) | 2008-10-16 |
| JP2008514568A (ja) | 2008-05-08 |
| MX2007003164A (es) | 2007-10-23 |
| ATE489997T1 (de) | 2010-12-15 |
| PL1791601T3 (pl) | 2011-07-29 |
| AU2005287473A1 (en) | 2006-03-30 |
| RU2007115160A (ru) | 2009-01-20 |
| EP1791601A1 (de) | 2007-06-06 |
| DE102004046391A1 (de) | 2006-04-06 |
| CA2579787A1 (en) | 2006-03-30 |
| WO2006032533A1 (de) | 2006-03-30 |
| DE502005010631D1 (de) | 2011-01-13 |
| EP1791601B1 (de) | 2010-12-01 |
| CN101084042A (zh) | 2007-12-05 |
| US7648698B2 (en) | 2010-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021226436A8 (en) | Optimized nucleotide sequences encoding sars-cov-2 antigens | |
| PH12018502251A1 (en) | Formulations of an lsd1 inhibitor | |
| MX2017004592A (es) | Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos. | |
| WO2009043504A3 (en) | Use of apelin-36 and optionally beta-melanotropin as therapeutic agents, eg for treating aids or alzheimer | |
| WO2009033799A3 (en) | Use of a peptide as a therapeutic agent | |
| NZ759512A (en) | Delayed release compositions of linaclotide | |
| WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
| JP2014533733A5 (pt) | ||
| JP2011522839A5 (pt) | ||
| WO2009043476A3 (en) | Neuromedin s as a therapeutic agent | |
| JP2015110588A5 (pt) | ||
| MY178082A (en) | Solid pharmaceutical compositions and processes for their production | |
| NZ602111A (en) | Extended release formulations of rasagiline and uses thereof | |
| MY158809A (en) | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same | |
| WO2009046832A3 (en) | Short peptides used in medicine | |
| WO2009009759A3 (en) | Yersinia pestis antigens, vaccine compositions, and related methods | |
| WO2009033778A3 (en) | Mage-3 antigen and others for use as a therapeutic agent | |
| BRPI0515559A (pt) | vacina e método para a preparação da mesma | |
| WO2009040085A3 (en) | Use of exendin-4 and optionally salusin-alpha as therapeutic agent(s) | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| WO2010089443A3 (es) | FORMULACIONES FARMACÉUTICAS DE PÉPTIDOS INHIBIDORES DE TGF- β1 | |
| MX2020000164A (es) | Formulaciones de isotretinoína para la mucosa oral y métodos para usar las mismas. | |
| WO2009040047A3 (en) | Therapeutic uses of ghrelin and combinations with stresscopin | |
| IN2014DN09240A (pt) | ||
| WO2010085611A3 (en) | Mycoplasma gallisepticum formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 39/00 (2006.01), A61P 31/10 (2006.01), A61K 3 |